Gleason grading system


The Gleason grading system is used to help evaluate the prognosis of men with prostate cancer using samples from a prostate biopsy. Together with other parameters, it is incorporated into a strategy of prostate cancer staging which predicts prognosis and helps guide therapy. A Gleason score is given to prostate cancer based upon its microscopic appearance. Cancers with a higher Gleason score are more aggressive and have a worse prognosis. Pathological scores range from 2 through 10, with higher number indicating greater risks and higher mortality.
The histopathologic diagnosis of prostate cancer has implications for the possibility and methodology of Gleason scoring. For example, it is not recommended in for example signet-ring adenocarcinoma or urothelial carcinoma of the prostate, and the scoring should discount foamy cytoplasms seen in foamy gland carcinoma.
A total score is calculated based on how cells look under a microscope, with the first half of the score based on the dominant, or most common cell morphology, and the second half based on the non-dominant cell pattern with the highest grade. These two numbers are then combined to produce a total score for the cancer.

Specimens and processing

Most often, a urologist or radiologist will remove a cylindrical sample of prostate tissue through the rectum, using hollow needles, and biomedical scientists in a histology laboratory prepare microscope slides for H&E staining and immunohistochemistry for diagnosis by a pathologist. If the prostate is surgically removed, a pathologist will slice the prostate for a final examination.

Histologic patterns

A pathologist microscopically examines the biopsy specimen for certain "Gleason" patterns. These Gleason patterns are associated with the following features:
In the present form of the Gleason system, prostate cancer of Gleason patterns 1 and 2 are rarely seen. Gleason pattern 3 is by far the most common.

Primary, secondary and tertiary grades

After analyzing the tissue samples, the pathologist then assigns a grade to the observed patterns of the tumor specimen.
The pathologist then sums the pattern-number of the primary and secondary grades to obtain the final Gleason score. If only two patterns are seen, the first number of the score is that of the tumor's primary grade while the second number is that of the secondary grade, as described in the previous section. If three patterns are seen, the first number of the score would be the primary grade and the second number the pattern with the highest grade. For example, if the primary tumor grade was 2 and the secondary tumor grade was 3 but some cells were found to be grade 4, the Gleason score would be 2+4=6. This is a slight change from the pre-2005 Gleason system where the second number was the secondary grade.
Gleason scores range from 2 to 10, with 2 representing the most well-differentiated tumors and 10 the least-differentiated tumors. Gleason scores have often been categorized into groups that show similar biologic behavior: low-grade, intermediate-grade, moderate to poorly differentiated or high-grade.
More recently, an investigation of the Johns Hopkins Radical Prostatectomy Database led to the proposed reporting of Gleason grades and prognostic grade groups as: Gleason score ≤ 6 ; Gleason score 3+4=7 indicating the majority is pattern 3; Gleason score 4+3=7 where pattern 4 is dominant; Gleason score 4+4=8 ; Gleason scores 9-10. Prostate cancers with a Gleason score ≤ 6 usually have rather good prognoses.

Comments

Gleason architectural pattern and Gleason grade are interchangeable terms.
The Gleason Grade/Score has two main points: 1: Based on architectural patterns, rather than cytological ones. The Gleason System separates architectural features into 1 of 5 histological patterns. These are in decreasing differentiation order but increasing in number: Pattern 1 is the most differentiated and pattern 5 is the least differentiated.
2: The second feature of Gleason grading is that the grade is not based on the highest pattern within the tumor, instead it is a combination of the most often and second most often patterns seen. Gleason realized that prostatic carcinomas have multiple patterns and that the prognosis of prostatic carcinoma was split between the most prevalent and the second most prevalent neoplasm pattern. So using the Gleason system, the most prevalent and second most prevalent pattern, if at least 5% of the neoplasm, are added together equaling the overall Gleason score.
If for example the most prevalent pattern/grade is 2, and the second most prevalent is a 1, then the Gleason score is 2+1=3. If the neoplasm has only one pattern, the number of the pattern is doubled to obtain the score. For example a tumor is all pattern 1, the Gleason score would be 1+1=2. The most differentiated tumor will have, at highest, a Gleason score of 2, while the worst differentiated neoplasm will have a score of 10. So a Gleason Score/Grade can only be between 2 and 10, there is no 0 or 1 by definition.
The main way to tell the difference between a normal prostate gland and neoplastic glands is that prostatic glands normally have two cell layers in the glands, in adenocarcinoma the basal cell layer is lost so that you only have one top layer of cellular tissue usually ranging from columnar- pseudostratified in appearance.

Score descriptions

Using this system the most well-differentiated tumors have a Gleason score/grade of 2, and the least-differentiated tumors a score of 10. Range by definition is from 2-10, with architectural type being from 1-5 and always doubled or added together accordingly as described above. Gleason scores are often grouped based on similar behaviour: Grade 2-4 being well-differentiated neoplasm, Grade 5-6 intermediate-grade neoplasm, Grade 7 moderately - poorly differentiated grade neoplasm, Grade 8-10 high-grade neoplasm.

Gleason 1

Gleason pattern 1 is the most well differentiated tumor pattern. It is a well defined nodule of single/separate, closely/densely packed, back-to-back gland pattern that does not invade into adjacent healthy prostatic tissue. The glands are round to oval shaped and proportionally large, comparing them to Gleason pattern 3 tumors, and are approximately equal in size and shape to one another.

Gleason 2

Gleason 2 are fairly well circumscribed nodules of single, separate glands. However, the glands are looser in arrangement and not as uniform as in pattern 1. Minimal invasion by neoplastic glands into the surrounding healthy prostate tissue may be seen. Similar to Gleason 1, the glands are usually larger than those of Gleason 3 patterns, and are round to oval in shape. Thus the main difference between Gleason 1 and 2 is the density of packing of the glands seen and invasion is possible in Gleason 2, not in Gleason 1 by definition.

Gleason 3

Gleason 3 is a clearly infiltrative neoplasm, with extension into adjacent healthy prostate tissue. The glands alternate in size and shape, and are often long/angular. They are usually small/micro-glandular in comparison to Gleason 1 or 2 grades. However, some may be medium to large in size. The small glands of Gleason 3, in comparison to the small and poorly defined glands of pattern 4, are distinct glandular units. Mentally you could draw a circle around each of the glandular units in Gleason 3.

Gleason 4

Gleason pattern 4 glands are no longer single/separated glands like those seen in pattern 1-3. They look fused together, difficult to distinguish, with rare lumen formation vs Gleason 1-3 which usually all have open lumens within the glands, or they can be cribriform-. Fused glands are chains, nests, or groups of glands that are no longer entirely separated by stroma-. Fused glands contain occasional stroma giving the appearance of "partial" separation of the glands. Due to this partial separation, fused glands sometimes have a scalloped appearance at their edges.

Gleason 5

Neoplasms have no glandular differentiation. It is composed of sheets, solid cords, or individual cells. You should not see round glands with lumenal spaces that can be seen in the other types that resemble more the normal prostate gland appearance.

Prognosis

Gleason scores 2-4 are typically found in smaller tumors located in the transitional zone. These are typically found incidentally on surgery for benign prostatic hyperplasia.
The majority of treatable/treated cancers are of Gleason scores 5 - 7 and are detected due to biopsy after abnormal digital rectal exam or prostate specific antigen evaluation. A Gleason score of 7 can be 3+4= 7, where the majority is pattern 3, or it can be 4+3=7 which pattern 4 dominates resulting in a more advanced cancer. The cancer is typically located in the peripheral zone usually the posterior portion, explaining the rationale of performing the digital rectal exam.
Tumors with Gleason scores 8-10 tend to be advanced neoplasms that are unlikely to be cured. Although some evidence suggests that prostate cancers will become more aggressive over time, Gleason scores usually remain stable for a few years.
The Gleason scores then become part of the TNM or Whitmore-Jewett prostate cancer staging system to provide prognosis.

History

The Gleason scoring system takes its name from Donald Gleason, a pathologist at the Minneapolis Veterans Affairs Hospital, who developed it with colleagues at that facility in the 1960s.
In 2005 the International Society of Urological Pathology altered the Gleason system, refining the criteria and changing the attribution of certain patterns. It has been shown that this "modified Gleason score" has higher performance than the original one, and is currently assumed standard in urological pathology. In this form, it remains an important tool.
However, problematic aspects of the original Gleason grading system still characterize the 2005 revision. The predominant lowest score assigned is Gleason 3+3 = 6. Patients who are told their Gleason score is 6 out of 10 may interpret that they have a more aggressive intermediate cancer and experience greater anxiety. More importantly, some classification systems fail to clearly distinguish between Gleason 3+4 = 7 and Gleason 4+3 = 7, with the latter having a worse prognosis.
Therefore, in 2014 an international multidisciplinary conference convened to revise the 2005 system. A 5-point Gleason Grade grouping similar to those such as PI-RADS used with prostate MRI evaluations was proposed to denote prognostically distinct stratification. The number 1 would indicate the lowest-risk cancer while 5 would indicate the most aggressive disease. The system was tested and validated against 20,000 prostatectomy specimens and at least 16,000 biopsy samples. The majority of conference participants concurred on the superiority of the scale over the 2005 Gleason grading system, pointing to the likelihood that overtreatment could be avoided for patients whose cancer was assigned a 1. The World Health Organization's 2016 edition of Pathology and Genetics: Tumours of the Urinary System and Male Genital Organs has accepted the 2014 system, which can be used in conjunction with the 2005 Gleason system.